High-mobility group box 1 protein in endophthalmitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 7, 2008, Pages 1053-1058

  Arimura, Noboru ^a   Ki i, Yuya ^a   Hashiguchi, Teruto ^a   Sakamoto, Taiji ^a   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Endophthalmitis; High mobility group box 1 protein; Infection; Inflammation; Tissue damage

Indexed keywords

FORMALDEHYDE; HIGH MOBILITY GROUP B1 PROTEIN; PARAFFIN; PROTEIN ANTIBODY;

AGED; ARTICLE; CASE CONTROL STUDY; CELL INFILTRATION; CHOROID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENDOPHTHALMITIS; ENUCLEATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; RETINA MACULOPATHY; RETROSPECTIVE STUDY; VISUAL ACUITY; VITREOUS BODY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHOROID; ENDOPHTHALMITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HMGB1 PROTEIN; HUMANS; MALE; MIDDLE AGED; RETINA; RETINAL PERFORATIONS; RETROSPECTIVE STUDIES; VISUAL ACUITY; VITREOUS BODY;

EID: 44649157587     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0827-2     Document Type: Article

References (21)

1. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195
2. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331-342
3. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251
4. Ito T, Kawahara K, Nakamura T, Yamada S, Nakamura T, Abeyama K, Hashiguchi T, Maruyama I (2007) High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost 5:109-116
5. Hatada T, Wada H, Nobori T, Okabayashi K, Maruyama K, Abe Y, Uemoto S, Yamada S, Maruyama I (2005) Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost 94:975-979
6. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima T, Komiya S, Maruyama I (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48:971-981
7. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101:296-301
8. Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR (2006) Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res 82:807-815
9. Yamada S, Inoue K, Yakabe K, Imaizumi H, Maruyama I (2003) High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin Chem 49:1535-1537
10. Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE (2007) High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med 33:1347-1353
11. Hoppe G, Rayborn ME, Sears JE (2007) Diurnal rhythm of the chromatin protein Hmgb1 in rat photoreceptors is under circadian regulation. J Comp Neurol 501:219-230
12. Lemley CA, Han DP (2007) Endophthalmitis: A review of current evaluation and management. Retina 27:662-680
13. Russell JA (2006) Management of sepsis. N Engl J Med 355:1699-1713
14. Pathengay A, Shah GY, Das T, Sharma S (2006) Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis. Am J Ophthalmol 141:938-940
15. Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ (1999) Intravitreal dexamethasone in exogenous bacterial endophthalmitis: Results of a prospective randomised study. Br J Ophthalmol 83:1050-1055
16. Jiang W, Pisetsky DS (2007) Mechanisms of Disease: The role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis. Nat Clin Pract Rheumatol 3:52-58
17. Petropoulos IK, Vantzou CV, Lamari FN, Karamanos NK, Anastassiou ED, Pharmakakis NM (2006) Expression of TNF-alpha, IL-1beta, and IFN-gamma in Staphylococcus epidermidis slime-positive experimental endophthalmitis is closely related to clinical inflammatory scores. Graefes Arch Clin Exp Ophthalmol 244:1322-1328
18. Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, Sato Y, Hiraga N, Adachi N, Yoshino T, Nishibori M (2007) Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. Faseb J 21:3904-3916
19. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW, Lee MH, Han PL, Park JS, Lee JK (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 26:6413-6421
20. Pedrazzi M, Raiteri L, Bonanno G, Patrone M, Ledda S, Passalacqua M, Milanese M, Melloni E, Raiteri M, Pontremoli S, Sparatore B (2006) Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J Neurochem 99:827-838
21. Riedemann NC, Guo RF, Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9:517-524